News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,080 Results
Type
Article (30469)
Company Profile (119)
Press Release (278492)
Section
Business (82201)
Career Advice (286)
Deals (12644)
Drug Delivery (42)
Drug Development (48270)
Employer Resources (38)
FDA (6663)
Job Trends (6597)
News (148205)
Policy (12108)
Tag
Academia (2033)
Alliances (25125)
Alzheimer's disease (636)
Antibody-drug conjugate (ADC) (100)
Approvals (6659)
Artificial intelligence (95)
Bankruptcy (95)
Best Places to Work (5670)
Biotechnology (93)
Breast cancer (221)
Cancer (1615)
Career advice (265)
CAR-T (101)
Cell therapy (243)
Clinical research (37839)
Collaboration (359)
Compensation (100)
COVID-19 (1364)
C-suite (75)
Data (884)
Diabetes (55)
Diagnostics (3906)
Earnings (26005)
Events (48076)
Executive appointments (232)
FDA (7049)
Funding (308)
Gene therapy (87)
GLP-1 (233)
Government (1881)
Healthcare (9378)
Infectious disease (1405)
Inflammatory bowel disease (58)
IPO (6492)
Job creations (1166)
Job search strategy (248)
Layoffs (178)
Legal (2031)
Liver cancer (71)
Lung cancer (245)
Lymphoma (100)
Manufacturing (92)
Medical device (3837)
Medtech (3837)
Mergers & acquisitions (6306)
Metabolic disorders (135)
Neuroscience (748)
NextGen: Class of 2025 (2737)
Non-profit (2700)
Northern California (968)
Obesity (67)
Opinion (90)
Pancreatic cancer (58)
People (25948)
Phase I (13613)
Phase II (16666)
Phase III (11482)
Pipeline (341)
Postmarket research (1335)
Preclinical (5900)
Prostate cancer (74)
Radiopharmaceuticals (230)
Rare diseases (120)
Real estate (2060)
Regulatory (9020)
Research institute (2081)
Series A (54)
Southern California (780)
Startups (1805)
United States (8007)
Vaccines (301)
Date
Today (66)
Last 7 days (207)
Last 30 days (970)
Last 365 days (17799)
2025 (860)
2024 (17972)
2023 (20329)
2022 (26408)
2021 (27618)
2020 (24981)
2019 (20771)
2018 (15478)
2017 (15633)
2016 (15207)
2015 (17557)
2014 (13261)
2013 (10773)
2012 (10996)
2011 (11438)
2010 (10590)
Location
Africa (305)
Arizona (68)
Asia (20710)
Australia (3951)
California (2050)
Canada (727)
China (240)
Colorado (103)
Connecticut (101)
Delaware (65)
Europe (46297)
Florida (293)
Georgia (56)
Illinois (205)
Indiana (107)
Japan (54)
Maryland (320)
Massachusetts (1584)
Minnesota (117)
New Jersey (677)
New York (677)
North Carolina (293)
Northern California (968)
Ohio (64)
Pennsylvania (376)
South America (398)
Southern California (780)
Texas (392)
Washington State (271)
309,080 Results for "netherlands cancer institute nci".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, announced a collaboration with Roche and the Netherlands Cancer Institute to conduct a new clinical trial in immune therapy unresponsive metastatic colon cancer.
June 14, 2024
·
4 min read
Press Releases
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
January 9, 2025
·
2 min read
Press Releases
SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI)
September 18, 2024
·
2 min read
Press Releases
Biosplice Therapeutics Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)
September 12, 2024
·
4 min read
Business
LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration
LIXTE Biotechnology Holdings, Inc. announced that it has signed an agreement to expand its collaboration with the Netherlands Cancer Institute and Oncode Institute to study drug synergies of LIXTE’s lead clinical compound, LB-100, with immunotherapy in various cancers.
October 16, 2023
·
5 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Business
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced a strategic collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health.
June 4, 2024
·
5 min read
Press Releases
BostonGene to Participate in the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
October 23, 2024
·
2 min read
Business
ATCC Announces Award from the National Cancer Institute to Provide Biospecimen Processing Services and Assays for Cancer Research
ATCC will continue to support the National Cancer Institute’s (NCI) mission to prevent cancer and the Division of Cancer Epidemiology and Genetics (DCEG) Biospecimen Activity and Assay Support (BAAS) program.
March 19, 2024
·
3 min read
Press Releases
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
January 7, 2025
·
3 min read
1 of 30,908
Next
